Ainhoa Madariaga

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 37

Top Topics

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

JCO global oncology

Nature communications

Cancer research communications

This page only lists publications with an associated author ORCID identifier.

Publications

Luisa Bonilla, Lawrence Kasherman, Luis Manso, Ainhoa Madariaga
Mirvetuximab soravtansine: an oasis in the desert? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Luisa Bonilla, Lawrence Kasherman, Luis Manso, Ainhoa Madariaga
Mirvetuximab soravtansine: an oasis in the desert? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Luisa Bonilla, Lawrence Kasherman, Luis Manso, Ainhoa Madariaga
Mirvetuximab soravtansine: an oasis in the desert? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (4) (2024)
Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar, Omar Abdihamid, Laure-Anne Teuwen, Nada Benhima, Ainhoa Madariaga, Safa Elkefi, Fernando Cristobal Diaz, Sadaqat Hussain, Kristina Jenei, Nazik Hammad, Miriam Mutebi, Fidel Rubagumya, Dario Trapani, Nadia El Kadmiri, Nasser Laouali, Maryam Fourtassi
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study. JCO global oncology 10 (2024)
Khalid El Bairi, Ainhoa Madariaga, Dario Trapani, Ouissam Al Jarroudi, Said Afqir
New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (5) (2024)
Ainhoa Madariaga, Nazlin Jivraj, Pamela Soberanis Pina, Faiza Somji, Tran Truong, Sheena Melwani, Mike Lovas, Terri-Ann Gogos, Katrina Sajewycz, Gita Bhat, Husam Alqaisi, Eduardo Gonzalez-Ochoa, Ana Carolina Veneziani, Vikas Garg, Neesha C Dhani, Robert Grant, Valerie Bowering, Amit M Oza, Lisa Wang, Alejandro Berlin, Pamela Denisse Soberanis-Piña
Electronic malignant bowel obstruction symptom monitoring smartphone application for patients with gynecologic cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar, Omar Abdihamid, Laure-Anne Teuwen, Nada Benhima, Ainhoa Madariaga, Safa Elkefi, Fernando Cristobal Diaz, Sadaqat Hussain, Kristina Jenei, Nazik Hammad, Miriam Mutebi, Fidel Rubagumya, Dario Trapani, Nadia El Kadmiri, Nasser Laouali, Maryam Fourtassi
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study. JCO global oncology 10 (2024)
Khalid El Bairi, Ainhoa Madariaga, Dario Trapani, Ouissam Al Jarroudi, Said Afqir
New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (5) (2024)
Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar, Omar Abdihamid, Laure-Anne Teuwen, Nada Benhima, Ainhoa Madariaga, Safa Elkefi, Fernando Cristobal Diaz, Sadaqat Hussain, Kristina Jenei, Nazik Hammad, Miriam Mutebi, Fidel Rubagumya, Dario Trapani, Nadia El Kadmiri, Nasser Laouali, Maryam Fourtassi
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study. JCO global oncology 10 (2024)
Khalid El Bairi, Salma Najem, Arman Reza Chowdhury, Abeid Omar, Omar Abdihamid, Laure-Anne Teuwen, Nada Benhima, Ainhoa Madariaga, Safa Elkefi, Fernando Cristobal Diaz, Sadaqat Hussain, Kristina Jenei, Nazik Hammad, Miriam Mutebi, Fidel Rubagumya, Dario Trapani, Nadia El Kadmiri, Nasser Laouali, Maryam Fourtassi
Conflict of Interest Disclosure in Oncology: Preliminary Insights From the Global ONCOTRUST-1 Cross-Sectional Study. JCO global oncology 10 (2024)
Ana C Veneziani, Eduardo Gonzalez-Ochoa, Husam Alqaisi, Ainhoa Madariaga, Gita Bhat, Marjan Rouzbahman, Suku Sneha, Amit M Oza
Heterogeneity and treatment landscape of ovarian carcinoma. Nature reviews. Clinical oncology (2023)
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, Neesha C Dhani, Waldo Jimenez, Stephen Welch, Helen MacKay, Josee-Lyne Ethier, Lucy Gilbert, Xuan Li, Angela Rodriguez, Lucy Chan, Valerie Bowering, Blaise Clarke, Tong Zhang, Ian King, Gregory S Downs, Tracy L Stockley, Lisa Wang, Smitha Udagani, Amit M Oza, Stephanie Lheureux
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma. Nature communications 14 (1) (2023)
Ainhoa Madariaga, Robert L Coleman, Antonio Gonzáles Martin
Novel therapies leading to a new landscape in gynecologic tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Ainhoa Madariaga, Robert L Coleman, Antonio Gonzáles Martin
Novel therapies leading to a new landscape in gynecologic tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Blanca Gil-Ibañez, Álvaro Tejerizo, M Reyes Oliver, Ainhoa Madariaga, Maria Maiz Jimenez, Alejandra Gil Garcia, Gregorio López González
Side effects screening and early intervention to impact in quality of life of patients with gynecological cancers (HALIS study). International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ainhoa Madariaga, Rodrigo Sanchez-Bayona, Fernanda G Herrera, Pedro T Ramirez, Antonio Gonzáles Martin
Outcomes and endpoints of relevance in gynecologic cancer clinical trials. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Ainhoa Madariaga, Rodrigo Sanchez-Bayona, Fernanda G Herrera, Pedro T Ramirez, Antonio Gonzáles Martin
Outcomes and endpoints of relevance in gynecologic cancer clinical trials. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, Neesha C Dhani, Waldo Jimenez, Stephen Welch, Helen MacKay, Josee-Lyne Ethier, Lucy Gilbert, Xuan Li, Angela Rodriguez, Lucy Chan, Valerie Bowering, Blaise Clarke, Tong Zhang, Ian King, Gregory S Downs, Tracy L Stockley, Lisa Wang, Smitha Udagani, Amit M Oza, Stephanie Lheureux
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma. Nature communications 14 (1) (2023)
Ainhoa Madariaga, Robert L Coleman, Antonio Gonzáles Martin
Novel therapies leading to a new landscape in gynecologic tumors. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Khalid El Bairi, Ainhoa Madariaga, Dario Trapani, Ouissam Al Jarroudi, Said Afqir
New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ainhoa Madariaga, Swati Garg, Nairi Tchrakian, Neesha C Dhani, Waldo Jimenez, Stephen Welch, Helen MacKay, Josee-Lyne Ethier, Lucy Gilbert, Xuan Li, Angela Rodriguez, Lucy Chan, Valerie Bowering, Blaise Clarke, Tong Zhang, Ian King, Gregory S Downs, Tracy L Stockley, Lisa Wang, Smitha Udagani, Amit M Oza, Stephanie Lheureux
Clinical outcome and biomarker assessments of a multi-centre phase II trial assessing niraparib with or without dostarlimab in recurrent endometrial carcinoma. Nature communications 14 (1) (2023)
Soyoun Rachel Kim, Ainhoa Madariaga, Liat Hogen, Danielle Vicus, Allan Covens, Carlos Parra-Herran, Pamela Denisse Soberanis-Piña, Lilian T Gien
Impact of lymphadenectomy and intra-operative tumor rupture on survival in early-stage mucinous ovarian cancers. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Khalid El Bairi, Ainhoa Madariaga, Dario Trapani, Ouissam Al Jarroudi, Said Afqir
New horizons for platinum-resistant ovarian cancer: insights from the 2023 American Society of Clinical Oncology (ASCO) and European Society for Medical Oncology (ESMO) Annual Meetings. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2023)
Ainhoa Madariaga, Rodrigo Sanchez-Bayona, Fernanda G Herrera, Pedro T Ramirez, Antonio Gonzáles Martin
Outcomes and endpoints of relevance in gynecologic cancer clinical trials. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 33 (3) (2023)
Stéphanie Lheureux, Stephenie D Prokopec, Leslie E Oldfield, Eduardo Gonzalez-Ochoa, Jeffrey P Bruce, Derek Wong, Arnavaz Danesh, Dax Torti, Jonathan Torchia, Alexander Fortuna, Sharanjit Singh, Matthew Irving, Kayla Marsh, Bernard Lam, Vanessa Speers, Aleksandra Yosifova, Ana Oaknin, Ainhoa Madariaga, Neesha C Dhani, Valerie Bowering, Amit M Oza, Trevor J Pugh
Identifying mechanisms of resistance by circulating tumour DNA in EVOLVE, a Phase II Trial of Cediranib Plus Olaparib for Ovarian Cancer at time of PARP Inhibitor Progression. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Sofia Aragon-Sanchez, M Reyes Oliver-Perez, Ainhoa Madariaga, M Jose Tabuenca, Mario Martinez, Alberto Galindo Izquierdo, M Luisa Arroyo, Marta Gallego, Marta Blanco, Eva Ciruelos Gil
Accuracy and Limitations of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Breast Cancer Patients with Positive Nodes. The breast journal 2022 (2022)
Rodrigo Sánchez-Bayona, Maira Bes-Rastrollo, Cesar Ignacio Fernandez-Lázaro, Maite Bastyr, Ainhoa Madariaga, Juan José Pons, María Ángeles Martínez, Estefania Toledo-Atucha
Vitamin D and Risk of Obesity-Related Cancers: Results from the SUN ('Seguimiento Universidad de Navarra') Project. Nutrients 14 (13) (2022)
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Sree Narayanan Nair, Zhu Juan Li, Zvi Shalev, Troy Ketela, Ilaria Colombo, Victoria Mandilaras, Michael Cabanero, Jeffrey P Bruce, Xuan Li, Swati Garg, Lisa Wang, Eric X Chen, Sarbjot Gill, Neesha C Dhani, Wenjiang Zhang, Melania Pintilie, Valerie Bowering, Marianne Koritzinsky, Robert Rottapel, Bradly G Wouters, Amit M Oza, Anthony M Joshua, Stephanie Lheureux
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer. Cancer research communications 2 (5) (2022)
Stefano Marastoni, Ainhoa Madariaga, Aleksandra Pesic, Sree Narayanan Nair, Zhu Juan Li, Zvi Shalev, Troy Ketela, Ilaria Colombo, Victoria Mandilaras, Michael Cabanero, Jeffrey P Bruce, Xuan Li, Swati Garg, Lisa Wang, Eric X Chen, Sarbjot Gill, Neesha C Dhani, Wenjiang Zhang, Melania Pintilie, Valerie Bowering, Marianne Koritzinsky, Robert Rottapel, Bradly G Wouters, Amit M Oza, Anthony M Joshua, Stephanie Lheureux
Repurposing Itraconazole and Hydroxychloroquine to Target Lysosomal Homeostasis in Epithelial Ovarian Cancer. Cancer research communications 2 (5) (2022)
Ainhoa Madariaga, Amit M Oza
Wee1 Inhibition in Recurrent Serous Uterine Cancer: Science Paving the Way in a Challenging Disease. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (14) (2021)
Michelle McMullen, Katherine Karakasis, Ainhoa Madariaga, Amit M Oza
Overcoming Platinum and PARP-Inhibitor Resistance in Ovarian Cancer. Cancers 12 (6) (2020)
Lawrence Kasherman, Ainhoa Madariaga, Marjan Rouzbahman, Kieran Murphy, David Shultz, Tracy Stockley, Amit M Oza
Across barriers: poly ADP-ribose polymerase inhibitors beyond progression in high grade serous ovarian cancer with brain metastases. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 31 (1) (2020)
Ainhoa Madariaga, Lawrence Kasherman, Katherine Karakasis, Pamela Degendorfer, Ann M Heesters, Wei Xu, Shahid Husain, Amit M Oza
Optimizing clinical research procedures in public health emergencies. Medicinal research reviews 41 (2) (2020)
Ainhoa Madariaga, Luisa Bonilla, Michelle McMullen, Amit M Oza, Stephanie Lheureux
Efficacy and safety updates of poly ADP-ribose polymerase (PARP) inhibitor maintenance in ovarian cancer from ASCO 2020. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 30 (8) (2020)
Ainhoa Madariaga, Lawrence Kasherman, Kathy Han, Stephanie Lheureux, Amit M Oza
Adjuvant treatment in early stage cervical cancer-does more equal better? International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 30 (9) (2020)
Ainhoa Madariaga, Valerie Bowering, Soha Ahrari, Amit M Oza, Stephanie Lheureux
Manage wisely: poly (ADP-ribose) polymerase inhibitor (PARPi) treatment and adverse events. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 30 (7) (2020)
Ainhoa Madariaga, Michelle McMullen, Semira Sheikh, Rajat Kumar, Fei-Fei Liu, Camilla Zimmermann, Shahid Husain, Gelareh Zadeh, Amit M Oza
COVID-19 Testing in Patients with Cancer: Does One Size Fit All? Clinical cancer research : an official journal of the American Association for Cancer Research 26 (18) (2020)